EUVIMEDEUVIMED entdecken
Crossref

Siglec Ligand Profiling on Extracellular Vesicles Reveals a Cancer‐Related Signature with Immunosuppressive Function in Pancreatic Cancer

Ping Li iD, Ruoxi Xiao, Feng Li, Xiangmao Bu iD, Fangli Cao, Jie Wang, Zhu Guo iD

Small · 2026

DOI: 10.1002/smll.75407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Ping Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People's Republic of China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Pancreatic Neoplasms, Sialic Acid Binding Immunoglobulin-like Lectins. Die Arbeit nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Taishan Scholars Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer‐derived extracellular vesicles (EVs) act as systemic carriers of functional sialic acids and participate in local or distant immune escape via the Siglec pathway. Therefore, assessing the expression of Siglec ligands on EVs can facilitate the exploration of novel cancer biomarkers and enable the evaluation of circulating sialic acid‐mediated immunosuppression. However, the structural complexity and functional redundancy of Siglec ligands pose challenges for evaluating their collective role in immune evasion. Here, an adjustable Siglec‐DNA barcoding platform is established for multiplexed detection of four Siglec ligands on EVs, thereby enabling the simultaneous profiling of multiple ligand‐receptor pairs in a single competitive assay. EV Siglec ligand signatures show statistical differences between cancer and normal groups, as quantified by the Siglec‐DNA platform in cell lines and clinical samples, highlighting their potential for pancreatic cancer discrimination. Specific types of Siglec ligands on EVs also inactivate natural killer (NK) cells and T cells in co‐culture, demonstrating their immunosuppressive potential. These findings uncover a novel, systemic mechanism of immune inhibition mediated by sialic acids, and also offer new insights into how EVs modulate cancer immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesPancreatic NeoplasmsSialic Acid Binding Immunoglobulin-like LectinsHumansLigandsCell Line, TumorKiller Cells, Natural

Stichwörter der Autor:innen

DNA barcodeextracellular vesiclespancreatic cancer discriminationsiglec ligands

Substanzen

LigandsSialic Acid Binding Immunoglobulin-like Lectins

Autor:innen und Institutionen

  • Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People's Republic of China.
  • Qilu Hospital (Qingdao), Shandong University, Qingdao, People's Republic of China.
  • Women and Children's Hospital, Qingdao University, Qingdao, People's Republic of China.

ORCID-Profile: Ping Li, Xiangmao Bu, Zhu Guo

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Taishan Scholars Foundation

Zitieren

APA

Li, P., Xiao, R., Li, F., Bu, X., Cao, F., Wang, J., & Guo, Z. (2026). Siglec Ligand Profiling on Extracellular Vesicles Reveals a Cancer‐Related Signature with Immunosuppressive Function in Pancreatic Cancer. Small. https://doi.org/10.1002/smll.75407

Vancouver

Li P, Xiao R, Li F, Bu X, Cao F, Wang J, et al. Siglec Ligand Profiling on Extracellular Vesicles Reveals a Cancer‐Related Signature with Immunosuppressive Function in Pancreatic Cancer. Small. 2026. doi:10.1002/smll.75407

BibTeX
@article{Li2026,
  author = {Li, Ping and Xiao, Ruoxi and Li, Feng and Bu, Xiangmao and Cao, Fangli and Wang, Jie and Guo, Zhu},
  title = {Siglec Ligand Profiling on Extracellular Vesicles Reveals a Cancer‐Related Signature with Immunosuppressive Function in Pancreatic Cancer},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.75407}
}
Kostenlos starten →